LifeStance Health Group, Inc.

LFST - CIK 0001845257

Market cap$3.02 B

Rank#1799

SEC filings452

LifeStance Health Group, Inc. trades as LFST and has a market capitalization of $3.02 B, making it the #1799 largest US-listed company by market value. In its fiscal 2025 annual report the company posted revenue of $1.42B, up 13.9% from the prior year and net income of $9.66M. This page tracks LifeStance Health Group, Inc. through 452 SEC filings, with financial statements and metrics updated as new reports are filed.

Key metrics

Revenue (latest FY)$1.42BFY 2025

Net income (latest FY)$9.66MFY 2025

Operating cash flow (latest FY)$146.15MFY 2025

Total assets (latest FY)$2.20BFY 2025

Net margin0.7%latest FY

Financial performance

Over the last 6 fiscal years LifeStance Health Group, Inc.'s revenue grew from $212.52M to $1.42B, a compound annual growth rate of 37.3%. Net profit margin compressed from 2.7% to 0.7% over the same period - every figure below comes from the company's audited annual filings.

LFST annual revenueView details

LFST annual net incomeView details

Key statistics

Market cap: $3.02 B
Share price (derived)market cap / shares outstanding: $7.78
P/E ratio (trailing FY): 312.1
Shares outstandingas of 2026-04-29: 0.39B
Total equityas of 2026-03-31: $1.48B
Return on equity: 0.7%
Long-term debtas of 2026-03-31: $282.75M
Cash & equivalentsas of 2026-03-31: $194.80M

Latest filings

Filing	Type	Filed
SCHEDULE 13G/A	-	2026-05-15
Insider trade	4	2026-05-14
Insider trade	4	2026-05-14
Insider trade	4	2026-05-14
Insider trade	4	2026-05-14
Major company event	8-K	2026-05-12
Insider trade	4	2026-05-11
SCHEDULE 13G/A	-	2026-05-08

Browse the full filing history (452 filings)

Recent press releases

LifeStance Health Group Announces Pricing of Secondary Public Offering2026-05-07
LifeStance Health Group Announces Pricing of Secondary Public Offering | LifeStance Health Inc.
LifeStance Health Group Announces Launch of Secondary Public Offering2026-05-07
LifeStance Health Group Announces Launch of Secondary Public Offering | LifeStance Health Inc.
LifeStance Reports First Quarter 2026 Results2026-05-07
LifeStance Reports First Quarter 2026 Results | LifeStance Health Inc.
LifeStance to Host First Quarter 2026 Earnings Conference Call on May 7, 20262026-05-07
A real-time audio webcast can be accessed via the Events and Presentations section of the LifeStance Investor Relations website ( https://investor.lifestance.com ), where related materials will be posted prior to the conference call.
LifeStance to Present at Upcoming Investor Conferences2026-04-29
LifeStance to Present at Upcoming Investor Conferences | LifeStance Health Inc.

Similar companies

The largest companies sharing LifeStance Health Group, Inc.'s SEC industry classification (services-health services).

PIIIP3 Health Partners$2.96 B LFST vs PIII

PRVAPrivia Health Group, Inc.$2.86 B LFST vs PRVA

WGSGeneDx Holdings Corp.$1.65 B LFST vs WGS

PNTGThe Pennant Group, Inc.$1.14 B LFST vs PNTG

INNVInnovAge Holding Corp.$1.02 B LFST vs INNV

Frequently asked questions

What is LifeStance Health Group, Inc.'s market cap?

LifeStance Health Group, Inc. (LFST) has a market capitalization of $3.02 B as of 2026-06-10, ranking #1799 among US-listed companies.

How much revenue does LifeStance Health Group, Inc. make?

LifeStance Health Group, Inc. reported revenue of $1.42B for fiscal year 2025, an increase of 13.9% year over year.

Is LifeStance Health Group, Inc. profitable?

Yes. LifeStance Health Group, Inc. reported net income of $9.66M in its latest fiscal year.

Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.